APA (7th ed.) Citation

Gao, Y., Wang, L., Lv, N., Yan, C., Huo, X., & Diao, R. Cost-effectiveness analysis of penpulimab combined with paclitaxel and carboplatin as a first-line treatment for metastatic squamous non-small cell lung cancer in China. BMJ Publishing Group.

Chicago Style (17th ed.) Citation

Gao, Yuan, Liangxiao Wang, Na Lv, Chunyan Yan, Xuechen Huo, and Ruigang Diao. Cost-effectiveness Analysis of Penpulimab Combined with Paclitaxel and Carboplatin as a First-line Treatment for Metastatic Squamous Non-small Cell Lung Cancer in China. BMJ Publishing Group.

MLA (9th ed.) Citation

Gao, Yuan, et al. Cost-effectiveness Analysis of Penpulimab Combined with Paclitaxel and Carboplatin as a First-line Treatment for Metastatic Squamous Non-small Cell Lung Cancer in China. BMJ Publishing Group.